10 Myths of Prostate Cancer
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …
Proton Radiation Therapy for Prostate Cancer
BY MARK SCHOLZ, MD Proton radiation is an enhanced type of radiation gaining in popularity for the treatment of prostate cancer. Men who are contemplating proton radiation need to compare …
10 Ways to Cope With Prostate Cancer: How to Achieve the Best Outcome
BY MARK SCHOLZ, MD Every year, 200,000 men are diagnosed with prostate cancer. Confusion about optimal treatment is widespread. The doctors even defer to their patients saying, “Since it’s about …
Can You Take Testosterone If You Have Prostate Cancer?
BY MARK SCHOLZ, MD A certain question frequently arises in my daily medical practice. Patients ask, “I have a history of prostate cancer but my testosterone levels are low. Can I take …
Is It Possible to Substitute a Scan for Prostate Biopsy?
BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy – targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …
Elevated PSA From Screening: What to Do?
BY MARK SCHOLZ, MD The PSA assay, along with cholesterol and other tests, is a common component of the blood testing that occurs during a man’s annual physical examination. But …
Selecting the Best Therapy for Newly-Diagnosed Prostate Cancer
BY MARK SCHOLZ, MD Due to the absence of well-designed comparative studies, treatment selection for prostate cancer has been highly controversial. However, in October 2016, two landmark articles published in the New England …
Prostate Biopsy and Alternatives
BY MARK SCHOLZ, MD It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer …
Preventing Hormone Therapy Side Effects
BY MARK SCHOLZ, MD A number of interventions are available that can substantially reduce adverse side effects from testosterone inactivating pharmaceuticals (TIP). Side effects vary from patient to patient and are influenced by the …
Jevtana and Provenge
BY MARK SCHOLZ, MD New prostate cancer drugs come to market quite rarely because the studies mandated by the FDA cost hundreds of millions of dollars. The FDA requires these studies to randomly allocate men into …